Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy
Liquid biopsy holds promise for identifying high-risk lung adenocarcinoma cases and serves as a complementary diagnostic tool in advanced stages, enhancing disease management strategies.
Authors
- Alison Wallace
- Michael D. Carter
- Stephanie Snow (ORCID: https://orcid.org/0000-0003-3847-0289)
- Tony Reiman (ORCID: https://orcid.org/0000-0002-2706-8764)
- Gopal P. Pathak
- Rashmi R. Shah (ORCID: https://orcid.org/0000-0002-8280-6467)
- Zhaolin Xu (ORCID: https://orcid.org/0000-0002-8553-4081)
- John Fris
Institutions
- University of New Brunswick (CA)
- Dalhousie University (CA)
- Saint John Regional Hospital (CA)
- Health Sciences Centre (CA)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3390/cancers17081340
- Citations
- 2
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- AstraZeneca Canada